Section Arrow
RCEL.NASDAQ
- Avita Medical
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 16.31
+0.69 (+4.42%)
Bid
15.62
Ask
16.5
High 16.31 
Low 15.31 
Volume 15.28K 
Regular Hours (Closed)
Last
 15.62
-0.37 (-2.31%)
Day High 
16.2626 
Prev. Close
15.99 
1-M High
18.43 
Volume 
386.98K 
Bid
15.62
Ask
16.5
Day Low
15.5 
Open
15.76 
1-M Low
13.29 
Market Cap 
506.69M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 16.43 
20-SMA 16.13 
50-SMA 13.84 
52-W High 18.43 
52-W Low 3.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.17/-3.24
Enterprise Value
508.82M
Balance Sheet
Book Value Per Share
-0.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.47M
Operating Revenue Per Share
1.29
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China,Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.